Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · Real-Time Price · USD
5.84
+0.12 (2.10%)
At close: Jun 29, 2026, 4:00 PM EDT
5.78
-0.06 (-1.10%)
After-hours: Jun 29, 2026, 6:02 PM EDT

Company Description

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system.

The company’s technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system.

It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders.

Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.

Autonomix Medical, Inc.
Autonomix Medical logo
Country United States
Founded 2014
Industry Medical Devices
Sector Healthcare
Employees 11
CEO Bradley Hauser

Contact Details

Address:
21 Waterway Avenue, Suite 300
The Woodlands, Texas 77380
United States
Phone 713 588 6150
Website autonomix.com

Stock Details

Ticker Symbol AMIX
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001617867
CUSIP Number 05330T304
ISIN Number US05330T3041
Employer ID 47-1607810
SIC Code 3841

Key Executives

Name Position
Jennifer Cook Chief Business Officer

Latest SEC Filings

Date Type Title
Jun 24, 2026 8-K Current Report
Jun 15, 2026 10-K/A [Amend] Annual report
May 27, 2026 10-K Annual Report
Apr 2, 2026 S-8 Securities to be offered to employees in employee benefit plans
Feb 11, 2026 10-Q Quarterly Report
Jan 16, 2026 8-K Current Report
Jan 9, 2026 8-K Current Report
Dec 12, 2025 424B3 Prospectus
Dec 11, 2025 EFFECT Notice of Effectiveness
Nov 26, 2025 S-3 Registration statement under Securities Act of 1933